Black Rock Inc. Alkermes Plc. Call Options Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
357Shares Held
180MCall Options Held
522KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA20.2MShares$486 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.9MShares$359 Million0.07% of portfolio
-
State Street Corp Boston, MA9MShares$217 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD8.33MShares$201 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY6.05MShares$146 Million2.63% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $3.96B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...